Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery.
2025 · 4th Quarter (Oct 1 - Dec 31)
CVS HEALTH
Filed by KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 15, 2026
- Income
- $30,000.00
- Expenses
- Not reported
- Client
- CVS HEALTH
- Filing UUID
- 2cc5ab41-493c-4a75-a461-2f2cd25681df
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.